Position in TERN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,060,824
+$1,969,670 QoQ
Shares Held
39,090
+18.4% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026OXFORD ASSET MANAGEMENT LLP holds $14,428,284 across 27 Biotechnology names. TERN ranks #2 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DAWN |
Day One Biopharmaceuticals, Inc.
|
99,747 | $2,138,575 | |
| 2 | TERN |
Terns Pharmaceuticals, Inc.
This page
|
39,090 | $2,060,824 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,499 | $1,115,903 | |
| 4 | ADMA |
Adma Biologics, Inc.
|
121,741 | $1,096,886 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
9,233 | $897,909 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
14,777 | $834,752 | |
| 7 | FOLD |
AMICUS THERAPEUTICS, INC.
|
49,811 | $720,267 | |
| 8 | ANAB |
Anaptysbio, Inc
|
12,676 | $703,010 |
All Filings in TERN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,060,824 | 39,090 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $91,154 | 33,027 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $85,626 | 15,456 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $100,032 | 14,689 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||